ZNF384 and osteosarcoma: Mounting evidence suggested that ZNF384 transactivated multiple downstream oncogenes, including HBO1 and MMP2, highlighting its tumorigenic function in osteosarcoma and colorectal cancer (Sakuma et al. 2012; Gao et al. 2021; Yan et al. 2022).